Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.
about
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophagesA distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growthCross-talk between integrin α6β4 and insulin-like growth factor-1 receptor (IGF1R) through direct α6β4 binding to IGF1 and subsequent α6β4-IGF1-IGF1R ternary complex formation in anchorage-independent conditionsSam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasisLoss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formationCCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisPriming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols.A radio-frequency coupling network for heating of citrate-coated gold nanoparticles for cancer therapy: design and analysis.Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.In vivo validation and 3D visualization of broadband ultrasound molecular imaging.Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature.Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery systemModeling metastasis biology and therapy in real time in the mouse lung.Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.A serum glycomics approach to breast cancer biomarkers.EMT tumorigenesis in the mouse mammary gland.GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer.An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasisFolate, DNA methylation, and mouse models of breast tumorigenesisInsulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth.Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.Alcohol consumption promotes mammary tumor growth and insulin sensitivity.The pathology of EMT in mouse mammary tumorigenesis.Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.Differential fates of biomolecules delivered to target cells via extracellular vesicles.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerRemodeling of endogenous mammary epithelium by breast cancer stem cellsInsulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetesIntegrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineageAllelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis.Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies.Genetic background may contribute to PAM50 gene expression breast cancer subtype assignmentsPeptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoLoss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.Slug promotes survival during metastasis through suppression of Puma-mediated apoptosis.Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance
P2860
Q27308841-39E04077-7612-4499-ACF5-EDE47A8937DDQ27345215-E9EBDD90-E358-431D-B1DF-870F230120BBQ28114971-734B4DEA-921A-4B8F-8760-230797FCAE99Q28235894-64B38BBD-D64E-4321-96E5-21C324176AE8Q28508528-81F82D62-28E9-406E-9829-7638E11FEDA3Q29614347-00516D03-0F94-42DA-BA23-DD2550BEC098Q30360210-85012386-A87F-42E0-B9B2-E2C4EE35CE72Q30426213-2003F920-BAE9-4371-9727-7B7084A3D22CQ30432690-C3657351-32AE-4DD9-B351-364BC6DD3A2EQ30451696-8C501864-5785-4E69-9D55-5D636DF9B0ECQ30452905-B78EC098-38E7-4BF7-8602-120D7CFAE7AAQ30477444-969A185B-8600-4DE8-8E03-C12639B663B9Q30495756-E6EB8B6F-CCEB-461F-B66A-0CBD8B64C331Q30514138-B2B2BD8E-D23D-423E-A4DC-CAA53436013AQ33250468-5E14C9AE-45B3-4899-A2E2-1CC6ECA81620Q33301901-AA0D72A7-34BD-42F4-8186-90B2285D9215Q33645920-5B68A414-CD57-4655-BB46-95E2C3ED4D38Q33658339-BEC8CC16-72D6-494B-95CE-108D90AC3C94Q33660202-31FA9248-D6DA-47E6-93BF-5CD1F5036937Q33688576-E668E037-073B-4DA1-8DBF-6A408C613AC6Q33714718-E86D4AF1-5B5E-4503-88AA-3B649952683FQ33777669-95DDD08E-02F5-4CF3-9492-930E9C02434BQ33849666-45C1C441-5F84-424E-9683-0E106C8F06E7Q33905831-820D68E8-C672-4488-B513-D33E874919FDQ33915129-6C19B802-687A-4417-B66F-932E186CFBE3Q33986152-7E7FE3EB-AF04-4242-B76F-A22BC6996144Q34043252-C9A95624-680B-42A0-8E5C-7CA1D8371FC3Q34056427-A59A6A9A-12F5-4365-87D7-F143FB24500FQ34154365-2146850C-CE8A-4FFC-BDB4-8E7AD94D4D2DQ34157626-1E127788-E42F-494E-A2C7-25CD185B85EEQ34208426-B9613C86-ABFB-404C-A083-5BBCBC4D9214Q34302171-00D47668-E8AF-4B36-A1E6-336A89193B90Q34921801-EEA89E47-AB1D-4BB7-B63D-6ED1942DD136Q34978311-0897F41A-A8E6-4E84-B868-07FE7A2F1491Q34981442-0C576B6E-4BB2-4EC3-A3D2-248288B9E922Q35073267-4695326D-397F-4587-8B2E-BCD7B2956D74Q35166541-4AC78F15-A449-41EF-B300-7518A0D42894Q35623825-ED05CCE7-07A7-45AE-8457-AB28C6D19B7DQ35624725-3EBD6F6D-EA5A-4067-AAB3-E52B76D17F10Q35632940-D39819D0-FED2-4402-8AD2-99EA2069E1A3
P2860
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Syngeneic mouse mammary carcin ...... divergent metastatic behavior.
@en
type
label
Syngeneic mouse mammary carcin ...... divergent metastatic behavior.
@en
prefLabel
Syngeneic mouse mammary carcin ...... divergent metastatic behavior.
@en
P2093
P2860
P1476
Syngeneic mouse mammary carcin ...... divergent metastatic behavior.
@en
P2093
Alexander D Borowsky
Clifford G Tepper
Erik T McGoldrick
J Graeme Hodgson
Jeffrey P Gregg
Kent W Hunter
Lawrence J T Young
Robert D Cardiff
Ruria Namba
William J Muller
P2860
P2888
P356
10.1007/S10585-005-2908-5
P577
2005-01-01T00:00:00Z
P6179
1002502299